Home » Proteomic Biomarker Shop CS-Keys Closes Seed Round of VC Financing

Proteomic Biomarker Shop CS-Keys Closes Seed Round of VC Financing

Jul 18, 2006
NEW YORK (GenomeWeb News) - Proteomics company CS-Keys said yesterday that it has received a "significant" but undisclosed seed investment from Midwest VC firm Triathlon Medical Ventures.
 
CS-Keys, based in Indianapolis, will use the investment to continue researching and developing its cancer-specific biomarkers and supporting its marketing and regulatory strategies.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Drive Away the Flies

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

Fewer Transfusions Needed

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

This Week in Nature

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Alteration Here and There to Win

Futurism writes that gene doping could be the next generation of cheating in sports.

What's Popular?

In Proteomics & Protein Research

  1. IsoPlexis Uses Single-Cell Platform to Assess T Cell Activity in CAR-T Cancer Therapy

    Premium

  2. Advances in Mass Spec Push Single-Cell Proteomics Toward Feasibility

    Premium

  3. Top Down Proteomics Identifies Protein-Level Effects of KRAS Mutations in Colorectal Cancer

    Premium

  4. Pan-Cancer Mutation Study Identifies Protein Kinases Key to Tumor Suppression

    Premium

  5. Protagen Shifting to Focus on Cancer Immunotherapy

    Premium

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.